DV Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$47.3M Buy
+300,000
New +$47.4M 1.52% 22

Other funds holding XBI

DV Trading's XBI Position: Q3 2026 in Review

DV Trading reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 68% in Q3 2026, selling an estimated $788K and leaving 2,351 shares worth $371K. The position accounts for 0.01% of the portfolio, ranked #312.

DV Trading first reported a position in XBI in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.8M in Q1 2026. 964 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • DV Trading held 2,351 shares of State Street SPDR S&P Biotech ETF worth $371K as of Q3 2026.
  • DV Trading sold 4,994 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $788K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of DV Trading's portfolio in Q3 2026, its #312 holding.
  • DV Trading first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 4 quarters since.
  • DV Trading's State Street SPDR S&P Biotech ETF position peaked at $1.8M in Q1 2026.
  • 964 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on DV Trading's 13F filing for Q3 2026, filed 16 Nov 2026.